166 related articles for article (PubMed ID: 15706479)
1. Learning from peer assessment: the role of the external quality assurance multilaboratory thrombophilia test process.
Favaloro EJ
Semin Thromb Hemost; 2005 Feb; 31(1):85-9. PubMed ID: 15706479
[TBL] [Abstract][Full Text] [Related]
2. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
3. Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program.
Favaloro EJ; Bonar R
Semin Thromb Hemost; 2007 Apr; 33(3):235-42. PubMed ID: 17427057
[TBL] [Abstract][Full Text] [Related]
4. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program.
Jennings I; Kitchen S; Woods TA; Preston FE
Semin Thromb Hemost; 2005 Feb; 31(1):66-72. PubMed ID: 15706477
[TBL] [Abstract][Full Text] [Related]
5. External quality assessment and the laboratory diagnosis of thrombophilia.
Meijer P; Haverkate F
Semin Thromb Hemost; 2005 Feb; 31(1):59-65. PubMed ID: 15706476
[TBL] [Abstract][Full Text] [Related]
6. External quality assurance of DNA testing for thrombophilia mutations.
Hertzberg M; Neville S; Favaloro E; McDonald D
Am J Clin Pathol; 2005 Feb; 123(2):189-93. PubMed ID: 15842041
[TBL] [Abstract][Full Text] [Related]
7. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
9. Maternal thrombophilia and the risk of recurrence of preeclampsia.
Facchinetti F; Marozio L; Frusca T; Grandone E; Venturini P; Tiscia GL; Zatti S; Benedetto C
Am J Obstet Gynecol; 2009 Jan; 200(1):46.e1-5. PubMed ID: 18845284
[TBL] [Abstract][Full Text] [Related]
10. Laboratory investigation of hypercoagulability.
Francis JL
Semin Thromb Hemost; 1998; 24(2):111-26. PubMed ID: 9579632
[TBL] [Abstract][Full Text] [Related]
11. A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia.
Tripodi A
Semin Thromb Hemost; 2005 Feb; 31(1):25-32. PubMed ID: 15706472
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
13. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
De Bel AV; Van der Cruyssen GA; Devreese KM
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
[TBL] [Abstract][Full Text] [Related]
14. Laboratory investigation of thrombophilia.
Tripodi A; Mannucci PM
Clin Chem; 2001 Sep; 47(9):1597-606. PubMed ID: 11514392
[TBL] [Abstract][Full Text] [Related]
15. Arterial thrombosis and the role of thrombophilia.
Boekholdt SM; Kramer MH
Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
[TBL] [Abstract][Full Text] [Related]
16. Quality assurance issues and interpretation of assays.
Mackie I; Cooper P; Kitchen S
Semin Hematol; 2007 Apr; 44(2):114-25. PubMed ID: 17433904
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic issues in thrombophilia: a laboratory scientist's view.
Favaloro EJ
Semin Thromb Hemost; 2005 Feb; 31(1):11-6. PubMed ID: 15706470
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
19. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
Omar SZ; Qvist R; Khaing SL; Muniandy S; Bhalla S
J Obstet Gynaecol Res; 2008 Apr; 34(2):174-8. PubMed ID: 18412778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
